Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
6 Months Ended
Mar. 31, 2020
Mar. 31, 2019
OPERATING ACTIVITIES    
Net loss $ (4,115,610) $ (6,182,833)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 74,213 84,394
Amortization of intangible assets 158,184 154,617
Noncash change in right-of-use assets 154,325  
Noncash interest expense 2,306,387 2,536,695
Share-based compensation 1,296,178 913,465
Deferred income taxes (198,944) 24,710
Provision for obsolete inventory 229,047 51,924
Change in fair value of derivative liabilities (75,000) 403,000
Other 7,500 122,433
Changes in current assets and liabilities:    
Increase in accounts receivable (1,837,178) (54,603)
Increase in inventory (2,597,964) (748,095)
Increase in prepaid expenses and other assets (962,470) (73,589)
Increase (decrease) in accounts payable 1,110,928 (656,527)
Decrease in unearned revenue   (187,159)
Decrease in accrued expenses and other current liabilities (293,429) (391,011)
Decrease in operating lease liabilities (183,658)  
Net cash used in operating activities (4,927,491) (4,002,579)
INVESTING ACTIVITIES    
Capital expenditures (54,680) (644)
Net cash used in investing activities (54,680) (644)
FINANCING ACTIVITIES    
Proceeds from sale of shares in public offering, net of fees   9,400,000
Payment of costs related to public offering   (268,033)
Proceeds from sale of shares under common stock purchase agreement 1,227,000  
Installment payments on SWK credit agreement (944,612) (3,191,717)
Proceeds from stock option exercises 408,632 200,000
Proceeds from premium finance agreement 836,780  
Installment payments on premium finance agreement (277,965)  
Cash paid for debt portion of finance lease (5,302)  
Net cash provided by financing activities 1,244,533 6,140,250
Net (decrease) increase in cash (3,737,638) 2,137,027
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 6,295,152 3,759,509
CASH AND CASH EQUIVALENTS AT END OF PERIOD 2,557,514 $ 5,896,536
Supplemental disclosure of noncash activities:    
Right-of-assets recorded in exchange for lease liabilities 1,229,926  
Amortization of deferred costs related to common stock purchase agreement $ 34,759